These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Treatment strategies for insulin-dependent diabetics with ESRD: a cost-effectiveness decision analysis model. Douzdjian V; Ferrara D; Silvestri G Am J Kidney Dis; 1998 May; 31(5):794-802. PubMed ID: 9590189 [TBL] [Abstract][Full Text] [Related]
24. Health economic evaluations: the special case of end-stage renal disease treatment. Winkelmayer WC; Weinstein MC; Mittleman MA; Glynn RJ; Pliskin JS Med Decis Making; 2002; 22(5):417-30. PubMed ID: 12365484 [TBL] [Abstract][Full Text] [Related]
25. Variations in living donor graft rates by dialysis clinic: effect on outcome and cost of chronic renal failure therapy. Baltzan MA; Ahmed S; Baltzan RB; Marshall RP; Thoma EL; Nicol MF Clin Nephrol; 1997 Jun; 47(6):351-5. PubMed ID: 9202863 [TBL] [Abstract][Full Text] [Related]
26. [Health prospects in the alternative strategies of renal replacement therapies]. Kaló Z; Járay J; Nagy J; Megyesi A; Hídvégi M Orv Hetil; 2000 Aug; 141(32):1761-5. PubMed ID: 10979304 [TBL] [Abstract][Full Text] [Related]
27. [The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation]. Blotière PO; Tuppin P; Weill A; Ricordeau P; Allemand H Nephrol Ther; 2010 Jul; 6(4):240-7. PubMed ID: 20554257 [TBL] [Abstract][Full Text] [Related]
28. Health benefits and costs of screening for colorectal cancer in people on dialysis or who have received a kidney transplant. Wong G; Li MW; Howard K; Hua DK; Chapman JR; Bourke M; Turner R; Tong A; Craig JC Nephrol Dial Transplant; 2013 Apr; 28(4):917-26. PubMed ID: 23182812 [TBL] [Abstract][Full Text] [Related]
29. The management of end-stage renal disease in India. Mani MK Artif Organs; 1998 Mar; 22(3):182-6. PubMed ID: 9527276 [No Abstract] [Full Text] [Related]
30. The cost effectiveness of renal provision in the UK. Haycox A; Jones D J Manag Med; 1996; 10(1):6-15. PubMed ID: 10162928 [TBL] [Abstract][Full Text] [Related]
31. Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data. Mohnen SM; van Oosten MJM; Los J; Leegte MJH; Jager KJ; Hemmelder MH; Logtenberg SJJ; Stel VS; Hakkaart-van Roijen L; de Wit GA PLoS One; 2019; 14(8):e0220800. PubMed ID: 31415578 [TBL] [Abstract][Full Text] [Related]
32. Economic analysis of the treatment of end-stage renal disease treatment: living-donor kidney transplantation versus hemodialysis. Sánchez-Escuredo A; Alsina A; Diekmann F; Revuelta I; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Campistol JM; Oppenheimer F; Fernandez E Transplant Proc; 2015; 47(1):30-3. PubMed ID: 25645763 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of repeat medical procedures: kidney transplantation as an example. Hornberger JC; Best JH; Garrison LP Med Decis Making; 1997; 17(4):363-72. PubMed ID: 9343794 [TBL] [Abstract][Full Text] [Related]
34. [Costs of interventions for patients with chronic renal disease]. Arredondo A; Rangel R; de Icaza E Rev Saude Publica; 1998 Jun; 32(3):255-61. PubMed ID: 9778860 [TBL] [Abstract][Full Text] [Related]
35. The cost-effectiveness of transplantation with expanded donor kidneys. Whiting JF; Zavala EY; Alexander JW; First MR Transplant Proc; 1999; 31(1-2):1320-1. PubMed ID: 10083588 [TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness analysis of renal replacement therapy in Austria. Haller M; Gutjahr G; Kramar R; Harnoncourt F; Oberbauer R Nephrol Dial Transplant; 2011 Sep; 26(9):2988-95. PubMed ID: 21310740 [TBL] [Abstract][Full Text] [Related]
37. The health system in Chile: the nephrologist perspective. Ardiles LG; Poblete H; Ortiz M; Elgueta S; Cusumano AM; Vukusich A; Mezzano S J Nephrol; 2011; 24(2):149-54. PubMed ID: 21360477 [TBL] [Abstract][Full Text] [Related]
38. Hemodialysis versus peritoneal dialysis, which is cost-effective? Atapour A; Eshaghian A; Taheri D; Dolatkhah S Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):962-5. PubMed ID: 26354569 [TBL] [Abstract][Full Text] [Related]
39. Return on investment for financial assistance for living kidney donors in the United States. Mathur AK; Xing J; Dickinson DM; Warren PH; Gifford KA; Hong BA; Ojo A; Merion RM Clin Transplant; 2018 Jul; 32(7):e13277. PubMed ID: 29740879 [TBL] [Abstract][Full Text] [Related]
40. Update on dialysis economics in the UK. Sharif A; Baboolal K Perit Dial Int; 2011 Mar; 31 Suppl 2():S58-62. PubMed ID: 21364210 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]